Profile picture

Doctor Shigetaka KAGEYAMA

Shizuoka City Hospital, Shizuoka (Japan)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Cumulative LDL-cholesterol exposure after Index percutaneous coronary intervention and subsequent major adverse cardiac and cerebrovascular events
Presentation
Cumulative LDL-cholesterol exposure after Index percutaneous coronary intervention and subsequent major adverse cardiac and cerebrovascular events
See more
Systematic screening of risk factors in acute venous thrromboembolism population revealed the utility of PESI score as a predictor of 3-year prognosis -insights from COMMAND VTE registry.
Presentation
Systematic screening of risk factors in acute venous thrromboembolism population revealed the utility of PESI score as a predictor of 3-year prognosis -insights from COMMAND VTE registry.
See more
Ten-year mortality after percutaneous coronary intervention, off-pump and on-pump surgery for complex coronary artery disease - who is the winner?
Presentation
Ten-year mortality after percutaneous coronary intervention, off-pump and on-pump surgery for complex coronary artery disease - who is the winner?
See more
Inter-corelab agreement of angiography-derived wall shear stress distribution
Presentation
Inter-corelab agreement of angiography-derived wall shear stress distribution
See more
Does the pre-procedural pathophysiological pattern impact post-procedural hemodynamic outcomes and vessel prognosis in multivessel coronary artery disease?
Presentation
Does the pre-procedural pathophysiological pattern impact post-procedural hemodynamic outcomes and vessel prognosis in multivessel coronary artery disease?
See more
Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial
Presentation
Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial
See more
Angiographic derived physiological assessment after intervention for predicting 2-year vessel-oriented composite endpoints in Multivessel TALENT trial
Presentation
Angiographic derived physiological assessment after intervention for predicting 2-year vessel-oriented composite endpoints in Multivessel TALENT trial
See more
Risk stratification on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy - validation cohort
Presentation
Risk stratification on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy - validation cohort
See more
The major bleeding event is the stronger predictor of long term mortality rather than the coronary event in the secondary prevention of ischemic heart disease in Japan
Presentation
The major bleeding event is the stronger predictor of long term mortality rather than the coronary event in the secondary prevention of ischemic heart disease in Japan
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources